Stronger Than Prostate Cancer with Memorial
March 31, 2015
When Abbey learned he had prostate cancer, he chose Memorial Cancer Institute and Dr. Mark Soloway, chief of the uro-oncology program, for experience and expertise he could trust. His close friend recommended Dr. Soloway, and Abbey’s own research kept drawing him to the reputation of this leader in the field.
“Prostate cancer is one of the most common cancers currently in western society,” said Dr. Soloway. “Abbey wisely decided to look at his options. He considered surgery and radiation therapy, as well as not doing anything – active surveillance.”
After a lot of discussion, Dr. Soloway and Abbey decided that surgery offered him the greatest chance for a cure.
Memorial Cancer Institute scheduled Abbey’s surgery quickly, and after an uncomplicated procedure, he was able to go home the following day. Just a week later, Abbey was well enough to return to work.
“One can perform the surgery with little impact on a patient’s quality of life, and get him back to his normal activities very promptly,” Dr. Soloway said.
For prostate cancer, the individual biology of each patient’s cancer is more important, even, than early detection, according to Dr. Soloway. Collaboration is also important. Memorial Cancer Institute’s multidisciplinary approach means patients benefit from an entire team working together to plan the strongest course of care for each patient.
“Whether patients need surgery, radiation, chemotherapy or a combination of treatments, Memorial Cancer Institute is on their side,” Dr. Soloway said. “We have the technical capability and we have the expertise to manage each aspect of cancer care.”
Memorial Cancer Institute's commitment to patient- and family-centered also made an impact on Abbey.
"They even took excellent care of my wife," he said. “The attention was superb. We couldn't ask for better.”